LIXT — Lixte Biotechnology Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Lixte Biotechnology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.82	5.35	4.2	1.04	5.11
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5.09	5.56	4.31	1.15	5.18
Net Property, Plant And Equipment	—	—	—	—	7.56
Total Assets	5.09	5.56	4.31	1.15	12.7
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.303	0.396	0.314	0.318	1.33
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.303	0.396	0.314	0.318	3.07
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	4.79	5.17	3.99	0.827	9.66
Total Liabilities & Shareholders' Equity	5.09	5.56	4.31	1.15	12.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding